Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Uniphos Enter.
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 0.00 | 0.00 | 0.00 | 0.00 | 50.65 | 3.03 | 30.48 | 5.10 | 72.90 | 5.86 | 0.00 | 0.00 | 26.14 |
| Expenses + | 0.73 | 0.79 | 0.75 | 0.69 | 51.51 | 3.78 | 30.96 | 6.10 | 74.50 | 6.70 | 1.10 | 0.97 | 26.96 |
| Operating Profit | -0.73 | -0.79 | -0.75 | -0.69 | -0.86 | -0.75 | -0.48 | -1.00 | -1.60 | -0.84 | -1.10 | -0.97 | -0.82 |
| OPM % | -1.70% | -24.75% | -1.57% | -19.61% | -2.19% | -14.33% | -3.14% | ||||||
| Other Income + | 1.15 | 0.91 | 40.44 | 0.87 | 0.65 | 0.79 | 4.67 | 0.45 | 0.21 | 0.27 | 24.43 | 0.13 | 0.40 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 | 0.17 | 0.17 | 0.17 |
| Profit before tax | 0.20 | -0.09 | 39.48 | -0.03 | -0.42 | -0.15 | 3.86 | -1.91 | -1.58 | -0.74 | 23.16 | -1.01 | -0.59 |
| Tax % | -135.00% | 0.00% | 0.30% | 0.00% | 50.00% | 0.00% | 0.00% | -2.62% | 0.00% | 0.00% | 0.00% | 0.00% | 18.64% |
| Net Profit + | 0.47 | -0.08 | 39.36 | -0.03 | -0.63 | -0.15 | 3.86 | -1.86 | -1.58 | -0.74 | 23.16 | -1.01 | -0.70 |
| EPS in Rs | 0.07 | -0.01 | 5.66 | -0.00 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 | 3.33 | -0.15 | -0.10 |
Financials of Uniphos Enter.
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 32 |
| Expenses + | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 54 | 115 | 36 |
| Operating Profit | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | -4 |
| OPM % | -47% | -987% | -370% | -257% | -195% | -6% | -3% | -12% | ||||
| Other Income + | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 21 |
| Tax % | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | 1% | -22% | 1% |
| Net Profit + | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 21 |
| EPS in Rs | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | 2.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% | 103% | 1,242% | 118% |
Financials of Uniphos Enter.
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,062 | 2,728 | 2,433 |
| Borrowings + | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Liabilities + | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 2 | 100 | 171 |
| Total Liabilities | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,619 |
| Fixed Assets + | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 183 | 182 | 182 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 1,802 | 2,616 | 2,372 |
| Other Assets + | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 92 | 44 | 65 |
| Total Assets | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,619 |
Financials of Uniphos Enter.
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -8 | -2 | -2 | -3 | -3 | -2 | -5 | 1 | -1 | -3 | -3 | |
| Cash from Investing Activity + | 10 | 14 | -0 | 9 | -2 | 44 | -34 | 20 | 41 | 50 | 53 | |
| Cash from Financing Activity + | -1 | -11 | 0 | 0 | 0 | 0 | 0 | -24 | -39 | -45 | -41 | |
| Net Cash Flow | 1 | 1 | -2 | 5 | -5 | 42 | -38 | -3 | -0 | 1 | 9 | |
| Free Cash Flow | -8 | -2 | -2 | -3 | -3 | -2 | -5 | 1 | -1 | -3 | -3 | |
| CFO/OP | 870% | 93% | 105% | 109% | 93% | 77% | 117% | 91% | 90% | 90% | 66% |
Financials of Uniphos Enter.
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 298 | ||||
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 298 | ||||
| Working Capital Days | -1,982 | 24,772 | 6,680 | 4,434 | 17 | -11 | -6 | 37 | ||||
| ROCE % | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 0% | 1% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…